Skip to main content

Maternal and Perinatal Outcomes of Expectant Management of Full-Term, Low-Risk, Nulliparous Patients.

Publication ,  Journal Article
Tita, ATN; Doherty, L; Grobman, WA; Reddy, UM; Silver, RM; Mallett, G; Rice, MM; El-Sayed, YY; Wapner, RJ; Rouse, DJ; Saade, GR; Thorp, JM ...
Published in: Obstet Gynecol
February 1, 2021

OBJECTIVE: To compare risks of maternal and perinatal outcomes by completed week of gestation from 39 weeks in low-risk nulliparous patients undergoing expectant management. METHODS: We conducted a secondary analysis of a multicenter randomized trial of elective induction of labor at 39 weeks of gestation compared with expectant management in low-risk nulliparous patients. Participants with nonanomalous neonates, who were randomized to and underwent expectant management and attained 39 0/7 weeks of gestation, were included. Delivery gestation was categorized by completed week: 39 0/7-39 6/7 (39 weeks), 40 0/7-40 6/7 (40 weeks), and 41 0/7-42 2/7 (41-42 weeks) (none delivered after 42 2/7). The coprimary outcomes were cesarean delivery and a perinatal composite (death, respiratory support, 5-minute Apgar score 3 or less, hypoxic ischemic encephalopathy, seizure, sepsis, meconium aspiration syndrome, birth trauma, intracranial or subgaleal hemorrhage, or hypotension requiring vasopressor support). Other outcomes included a maternal composite (blood transfusion, surgical intervention for postpartum hemorrhage, or intensive care unit admission), hypertensive disorders of pregnancy, peripartum infection, and neonatal intermediate or intensive care unit admission. For multivariable analysis, P<.0125 was considered to indicate statistical significance for the coprimary outcomes. RESULTS: Of 2,502 participants who underwent expectant management, 964 (38.5%) delivered at 39 weeks of gestation, 1,111 (44.4%) at 40 weeks, and 427 (17.1%) at 41-42 weeks. The prevalence of medically indicated delivery was 37.9% overall and increased from 23.8% at 39 weeks of gestation to 80.3% at 41-42 weeks. The frequency of cesarean delivery (17.3%, 22.0%, 37.5%; P<.001) and the perinatal composite (5.1%, 5.9%, 8.2%; P=.03) increased with 39, 40, and 41-42 weeks of gestation, respectively, and hypertensive disorders of pregnancy decreased (16.4%, 12.1%, 10.8%, P=.001). The adjusted relative risk, 95% CI (39 weeks as referent) was significant for cesarean delivery at 41-42 weeks of gestation (1.93, 1.61-2.32) and for hypertensive disorders of pregnancy at 40 weeks (0.71, 0.58-0.88) and 41-42 weeks (0.61, 0.45-0.82). None of the other outcomes were significant. CONCLUSION: In expectantly managed low-risk nulliparous participants, the frequency of medically indicated induction of labor, and the risks of cesarean delivery but not the perinatal composite outcome, increased significantly from 39 to 42 weeks of gestation.

Duke Scholars

Published In

Obstet Gynecol

DOI

EISSN

1873-233X

Publication Date

February 1, 2021

Volume

137

Issue

2

Start / End Page

250 / 257

Location

United States

Related Subject Headings

  • Watchful Waiting
  • Pregnancy
  • Parity
  • Obstetrics & Reproductive Medicine
  • Labor, Induced
  • Humans
  • Female
  • Cesarean Section
  • 3215 Reproductive medicine
  • 1114 Paediatrics and Reproductive Medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tita, A. T. N., Doherty, L., Grobman, W. A., Reddy, U. M., Silver, R. M., Mallett, G., … for the                                  Eunice Kennedy Shriver                                  National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. (2021). Maternal and Perinatal Outcomes of Expectant Management of Full-Term, Low-Risk, Nulliparous Patients. Obstet Gynecol, 137(2), 250–257. https://doi.org/10.1097/AOG.0000000000004230
Tita, Alan T. N., Lindsay Doherty, William A. Grobman, Uma M. Reddy, Robert M. Silver, Gail Mallett, Madeline Murguia Rice, et al. “Maternal and Perinatal Outcomes of Expectant Management of Full-Term, Low-Risk, Nulliparous Patients.Obstet Gynecol 137, no. 2 (February 1, 2021): 250–57. https://doi.org/10.1097/AOG.0000000000004230.
Tita ATN, Doherty L, Grobman WA, Reddy UM, Silver RM, Mallett G, et al. Maternal and Perinatal Outcomes of Expectant Management of Full-Term, Low-Risk, Nulliparous Patients. Obstet Gynecol. 2021 Feb 1;137(2):250–7.
Tita, Alan T. N., et al. “Maternal and Perinatal Outcomes of Expectant Management of Full-Term, Low-Risk, Nulliparous Patients.Obstet Gynecol, vol. 137, no. 2, Feb. 2021, pp. 250–57. Pubmed, doi:10.1097/AOG.0000000000004230.
Tita ATN, Doherty L, Grobman WA, Reddy UM, Silver RM, Mallett G, Rice MM, El-Sayed YY, Wapner RJ, Rouse DJ, Saade GR, Thorp JM, Chauhan SP, Costantine MM, Chien EK, Casey BM, Srinivas SK, Swamy GK, Simhan HN, Macones GA, for the                                  Eunice Kennedy Shriver                                  National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Maternal and Perinatal Outcomes of Expectant Management of Full-Term, Low-Risk, Nulliparous Patients. Obstet Gynecol. 2021 Feb 1;137(2):250–257.

Published In

Obstet Gynecol

DOI

EISSN

1873-233X

Publication Date

February 1, 2021

Volume

137

Issue

2

Start / End Page

250 / 257

Location

United States

Related Subject Headings

  • Watchful Waiting
  • Pregnancy
  • Parity
  • Obstetrics & Reproductive Medicine
  • Labor, Induced
  • Humans
  • Female
  • Cesarean Section
  • 3215 Reproductive medicine
  • 1114 Paediatrics and Reproductive Medicine